Skip to main content
. Author manuscript; available in PMC: 2011 Sep 1.
Published in final edited form as: Int J Neuropsychopharmacol. 2010 Feb 11;13(8):997–1009. doi: 10.1017/S1461145710000039

Table 2.

Mean body weight gain at testing (weight at testing – starting weight)

Experiment Group Body weight gain
(Mean ± SEM, g)
F-Value
(*p<0.05)

Experiment 1
 3 days post-CIC Control 18.67 ± 5.80
CIC 14.33 ± 3.77 F 1,22 =4.70*
 7 days post-CIC Control 22.36 ± 6.55
CIC 18.33 ± 9.02 F 1,21 =1.48
 14 days post-CIC Control 26.25 ± 2.92
CIC 22.80 ± 2.81 F 1,16 =0.80
 21 days post-CIC Control 36.63 ± 2.72
CIC 31.50 ± 1.63 F 1,16 =3.22

Experiment 2
 2-week CIC Control 18.75 ± 14.48
CIC 11.63 ± 10.51 F 1,10 =0.18
 5-week CIC Control 91.50 ± 10.74
CIC 88.86 ± 9.75 F 1,9 =0.04

Experiment 3
 Chronic CIT Control-Veh 65.33 ± 4.27
Control-Cit 59.71 ± 8.56 F 1,26 =0.02 (Drug)
CIC-Veh 52.71 ± 7.58 F 1,26 =1.74 (Stress)
CIC-Cit 56.86 ± 4.57
 Chronic DMI Control-Veh 61.25 ± 5.45
Control-Cit 64.86 ± 4.48 F 1,25 =0.04 (Drug)
CIC-Veh 57.00 ± 6.58 F 1,25 =1.93 (Stress)
CIC-Cit 55.29 ± 4.48
 Acute CIT Control 14.63 ± 3.43
CIC 5.63 ± 3.86 F 1,30=4.33*
 Acute DMI Control 6.00 ± 5.21
CIC 3.33 ± 3.47 F 1,22 =0.20
*

p<0.05 compared to the corresponding control group